motilin-(1-13) (human) [5294]



motilin-(1-13) (human)


SMILES CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCSC)C(=O)O)[C@@H](C)O
InChIKey BYENHSKWDFWKRW-JAFQCPPXSA-N
Sequence FVPIFTYGELQRM
HELM PEPTIDE1{F.V.P.I.F.T.Y.G.E.L.Q.R.M}$$$$

Chemical Properties

Hydrogen bond acceptors 20
Hydrogen bond donors 19
Rotatable bonds 49
Log P -2.147
Molecular weight (Da) 1599.8
Stereochemistry info partial

Database connections

Model (AF2) motilin


Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

motilin-(1-13) (human)


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Model (AF2) motilin


Compound is not listed as a drug.